Request Appointment
Rush University Cancer Center1520 W Harrison StChicago, IL 60607
Overview of Dr. Ross
Dr. Helen Ross is an oncologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center and Mayo Clinic Hospital. She received her medical degree from David Geffen School of Medicine at UCLA and has been in practice 33 years. Dr. Ross accepts several types of health insurance, listed below. She is one of 76 doctors at Mayo Clinic Hospital and one of 60 doctors at Rush University Medical Center who specialize in Oncology. She has more than 100 publications and over 500 citings.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990
Cedars-Sinai Medical CenterResidency, Internal Medicine, 1984 - 1987
David Geffen School of Medicine at UCLAClass of 1984
Certifications & Licensure
AZ State Medical License 2007 - 2027
CA State Medical License 1985 - 2027
IL State Medical License 2023 - 2026
OR State Medical License 1997 - 2025
CO State Medical License 2022 - 2023
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Trial of Poor Performance Status Patients (ToPPS) Start of enrollment: 2009 Jun 01
- Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2012 Apr 01
- A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib
- Join now to see all
Publications & Presentations
PubMed
- The Utility of Immune Checkpoint Inhibition in the Management of Resectable Non-Small Cell Lung Cancer.Louis Filipiak, Koosha Paydary, Mary Jo Fidler, Helen J Ross
Cancers. 2025-07-25 - 12 citationsAtezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled Trial.Helen J Ross, David Kozono, Xiaofei F Wang, James John Urbanic, Terence M Williams
JAMA Oncology. 2024-09-01 - 3 citationsA Review of Concurrent Chemo/Radiation, Immunotherapy, Radiation Planning, and Biomarkers for Locally Advanced Non-small Cell Lung Cancer and Their Role in the Develop...John Michael Varlotto, Zhuoxin Sun, Bonnie Ky, Jenica Upshaw, Thomas J Fitzgerald
Clinical Lung Cancer. 2022-11-01
Press Mentions
The Evolution of Lung Cancer Detection and CareJuly 25th, 2025
Double Cancer Diagnosis Leads Arizona Couple to Mayo Clinic for CareDecember 3rd, 2017
Mesothelioma Patient Finds Complex, Comprehensive AnswerJuly 12th, 2017
Grant Support
- Cyclosporine Enhancement Of Paclitaxel In Lung CancerNational Cancer Institute1997–1999
- Cyclosporine Enhancement Of Paclitaxel In Lung CancerNational Cancer Institute1996–1997
- Regulation Of Cytokine MRNA Stability In Tumor CellsNational Cancer Institute1991–1995
Professional Memberships
- Member
- Member
- Member
- International Association for the Study of Lung CancerMember
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Georgia Blue Choice HMO
BCBS Georgia Blue Open Access POS
BCBS Georgia BlueChoice Option POS
CIGNA HMO
CIGNA Open Access
CIGNA PPOCofinity PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
